SAN DIEGO --(BUSINESS WIRE)--Feb. 24, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2020 and financial guidance for the year ending December 31, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Feb. 16, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: Citi 2021 Healthcare Services, Medtech,
SAN DIEGO --(BUSINESS WIRE)--Jan. 19, 2021-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2020 results after the financial markets close on Wednesday, February 24, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Dec. 14, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant (Raj) Singh Sodhi as an independent member of its board of directors effective January 1, 2021 .
SAN DIEGO --(BUSINESS WIRE)--Nov. 23, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Control-IQ™ technology. Control-IQ technology is an advanced hybrid
SAN DIEGO --(BUSINESS WIRE)--Nov. 5, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2020 and updated its sales guidance for the year ending December 31, 2020 .
SAN DIEGO --(BUSINESS WIRE)--Oct. 30, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following virtual investor conferences: 29 th Annual Credit Suisse Healthcare
SAN DIEGO --(BUSINESS WIRE)--Oct. 8, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2020 results after the financial markets close on Thursday, November 5, 2020 .
SAN DIEGO --(BUSINESS WIRE)--Sep. 2, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present a company update at the following virtual investor conferences:
SAN DIEGO --(BUSINESS WIRE)--Aug. 27, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by the New England Journal of Medicine (NEJM) of results from the Protocol 5 study (DCLP5) of the International Diabetes
SAN DIEGO --(BUSINESS WIRE)--Jul. 30, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2020 . In addition, the Company provided sales guidance for the year ending
SAN DIEGO --(BUSINESS WIRE)--Jul. 29, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as an independent member of its board of directors effective August 3, 2020 . Ms.
DUBLIN & SAN DIEGO --(BUSINESS WIRE)--Jul. 9, 2020-- Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes.
SAN DIEGO --(BUSINESS WIRE)--Jul. 8, 2020-- JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Tandem Diabetes Care (NASDAQ: TNDM), a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary
SAN DIEGO --(BUSINESS WIRE)--Jul. 7, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2020 results after the financial markets close on Thursday, July 30, 2020 .
- Companies partner to integrate Abbott's FreeStyle Libre continuous glucose monitoring technology with Tandem's insulin delivery products to provide options to simplify and tailor diabetes management ABBOTT PARK, Ill. and SAN DIEGO , June 29, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) and Tandem
SAN DIEGO --(BUSINESS WIRE)--Jun. 24, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its acquisition of Sugarmate, a popular mobile app for people with diabetes who use insulin.
SAN DIEGO --(BUSINESS WIRE)--Jun. 17, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of an expanded pediatric indication for the t:slim X2™ insulin pump with Control-IQ™
SAN DIEGO --(BUSINESS WIRE)--Jun. 13, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today presented positive real-world data from early use of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed loop technology,
SAN DIEGO --(BUSINESS WIRE)--Jun. 4, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Kathleen McGroddy-Goetz , Ph.D., as an independent member of its Board of Directors effective June 8, 2020 . Dr.
